Streetbeat News

Equity Actions

EYEN

Eyenovia, Inc. has announced a $4 million registered direct offering involving the sale of 8,695,653 shares and warrants at $0.46 per share. The proceeds will fund commercialization, clinical studies, and general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:33 pm

ADTX

Aditxt has announced a 1-for-40 reverse stock split effective at the open of trading on October 2. This corporate action is aimed at increasing the per-share trading price of its common stock.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:17 pm

NVNO

EnVVeno Medical's stock is trading lower following the announcement of a $15 million public offering, pricing 4.3 million shares at $3.50 each.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:12 pm

TOVX

Theriva Biologics shares declined following the announcement of a $2.5 million offering with new warrants priced at $1.75 per share.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:11 pm

ONCO

Onconetix shares rose after Altos Venture disclosed a 32.5% stake in the company in a 13D filing.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:10 pm

MLNK

MeridianLink's shares are trading lower following the announcement of a secondary public offering of 6,000,000 shares.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:01 pm

VERO

Venus Concept has announced a $15 million debt-to-equity exchange transaction, reducing its total debt obligations to approximately $34.6 million.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 11:40 am

XAIR

Beyond Air has announced a $20.6 million private placement offering of 40.39 million shares of its common stock. This financing is expected to strengthen the company's balance sheet and provide sufficient cash runway through June 2026.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 11:34 am

ONCO

Altos Venture has reported a 32.5% stake in Onconetix as of September 24, according to a 13D filing. This significant investment indicates Altos Venture's confidence in Onconetix's potential.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 11:17 am

ADRT

Ault Disruptive Technologies Corporation announced it will redeem its public shares and will not proceed with an initial business combination.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 10:33 am